The nasometry devices market involves diagnostic instruments that measure and monitor nasal airflow and physiology. Nasometers help assess and analyze nasal patency by detecting the sound frequency and amplitude made by inhaled and exhaled air through the nose. They provide accurate, reproducible, and non-invasive readings of nasal resistance which help in diagnosing various nasal conditions. Nasometers enable objective evaluation of nasal patency before and after treatment interventions to gauge their effectiveness. The growing incidence of sinusitis worldwide is a key factor boosting the demand for nasometry devices. Sinusitis affects around 30 million people in the US annually causing headaches, facial pain or pressure, nasal congestion, and fatigue. As nasal congestion is a hallmark symptom of sinusitis, monitoring nasal airflow using nasometry aids in effective management of the condition.
The Global Nasometry devices Market Demand is estimated to be valued at US$ 336.9 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period 2024 to 2031. Key players operating in the nasometry devices are GM Instruments Ltd., Rose Medical Solutions Ltd., PENTAX Medical, Otopront GmbH, BioRESEARCH Associates, Inc., Medtronic, Homoth Medizinelektronik, Recorders & Medicare Systems Private Limited, Atmos MedizinTechnik GmbH & Co.KG, Collin Medical, Euroclinic MediCare Solutions, SWORD MEDICAL LTD., Glottal Enterprises Incorporated, and Vivos Therapeutics Inc.
Key Takeaways
Key players operating in the nasometry devices are GM Instruments Ltd., Rose Medical Solutions Ltd., PENTAX Medical, Otopront GmbH, BioRESEARCH Associates, Inc., Medtronic, Homoth Medizinelektronik, Recorders & Medicare Systems Private Limited, Atmos MedizinTechnik GmbH & Co.KG, Collin Medical, Euroclinic MediCare Solutions, SWORD MEDICAL LTD., Glottal Enterprises Incorporated, and Vivos Therapeutics Inc. These companies are focusing on new product launches and geographical expansion to strengthen their market position.
The rising global prevalence of chronic sinusitis and other nasal conditions is fueling the demand for nasometry devices. As per reliable estimates, around 1.2 billion people suffer from sinusitis worldwide annually. Nasometry aids objective evaluation and improves management of such conditions.
The major players are also collaborating with healthcare providers and spreading awareness about nasometry-guided diagnosis and treatment. This is increasing the adoption of nasometry globally especially in emerging nations of Asia Pacific and Latin America. Various tradeshows and conferences help promote nasometry technology to ENT specialists across geographies.
Market drivers
The growing geriatric population is a major driver for the nasometry devices market. Older adults are more susceptible to chronic nasal conditions and sinusitis due to a weaker immune system and underlying diseases. Nasometry plays a critical role in objective assessment and monitoring treatment outcomes in the elderly population. Furthermore, technical advancements have made modern nasometers more portable, easy-to-use, and affordable. This is increasing the adoption of nasometry for diagnostic use even in remote areas and small clinics globally. The introduction of app-based nasometry systems is further expected to support market growth during the forecast period.
The United States represents the most valuable country market for nasometry devices globally supported by a large private healthcare sector, favourable insurance coverage for testing services, growing respiratory disorder prevalence rates, and technological advancements. However, budget cuts to federal health programs, rising prices of patented devices, and the COVID-19 pandemic impact are slowing market growth in the short-term. Instead, demand is surging in emerging economies like India, Brazil, and countries across the Middle East and Africa as their healthcare systems mature and standards of living improve.
For more insights, Read- Nasometry Devices Market
